• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Surveillance and Biometrics (OSB) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Data is current as of September 30, 2013

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 20118586
Nov 20118592
Dec 20118589
Jan 20128592
Feb 20128593
Mar 20128585
Apr 20128586
May 20128594
Jun 20128594
Jul 20128595
Aug 20128593
Sep 20128593

FY 2012 Overall: 91%

Number of OSB intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A237
Nov 2011N/A257
Dec 2011N/A225
Jan 2012N/A255
Feb 2012N/A270
Mar 2012N/A331
Apr 2012N/A239
May 2012N/A279
Jun 2012N/A305
Jul 2012N/A261
Aug 2012N/A309
Sep 2012N/A250

FY 2012 Total: 3,218

Total number of OSB intra- and inter-Office eConsults completed during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A276
Nov 2011N/A278
Dec 2011N/A254
Jan 2012N/A276
Feb 2012N/A290
Mar 2012N/A390
Apr 2012N/A279
May 2012N/A298
Jun 2012N/A323
Jul 2012N/A275
Aug 2012N/A333
Sep 2012N/A270

FY 2012 Total: 3,542

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.